500 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Inje... — RxCUI 1863975
RxNorm drug concept · Semantic clinical drug
RxCUI 1863975
Semantic clinical drug · SCD
● Current RxNorm concept 10 FDA products
10 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1863975
Official name500 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known as500 ML Glucose 50 MG/ML / K+ Chloride 0.02 MEQ/ML / NaCl 2.25 MG/ML Injection; potassium chloride 10 MEQ / dextrose 5 % / sodium chloride 0.225 % in 500 ML Injection; 500 ML Glucose 50 MG/ML / Pot Chloride 0.02 MEQ/ML / NaCl 2.25 MG/ML Injection; potassium chloride 10 MEQ / dextrose 5 % / sodium chloride 0.225 % per 500 ML Injection
FDA products mapped10
Package NDCs mapped10
Reported Medicaid activity (SDUD)5,763 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Potassium Chloride: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You're right that food is the first line — bananas, potatoes, and leafy greens are all rich in potassium. But sometimes diet alone isn't enough, especially if you're taking a diure...
- Why did my doctor prescribe potassium chloride? I thought potassium just came from bananas.
- Yes — always take oral tablets or capsules with a meal or right after eating. Taking them on an empty stomach can irritate or even ulcerate the lining of your stomach or intestines...
- Do I have to take it with food? What happens if I forget?
🕸️ Concept Web — How 500 ML glucose 50 MG/ML / potassium chloride 0.0... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
500 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection
RxCUI 1863975 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Glucose
4850IN -
Potassium chloride
8591IN -
Sodium chloride
9863IN -
Glucose / potassium chloride / sodium chloride
216554MIN
-
Glucose
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Glucose / potassium chloride / sodium chloride Injection
1863604SCDF -
Glucose / potassium chloride / sodium chloride Injectable Product
1165813SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Glucose / potassium chloride / sodium chloride Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Glucose 50 MG/ML
315789SCDC -
Potassium chloride 0.02 MEQ/ML
316538SCDC -
Sodium chloride 2.25 MG/ML
1794901SCDC
-
Glucose 50 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Glucose 50 MG/ML
SCDC · 315789 -
Potassium chloride 0.02 MEQ/ML
SCDC · 316538 -
Sodium chloride 2.25 MG/ML
SCDC · 1794901 -
Glucose / potassium chloride / sodium chloride Injection
SCDF · 1863604 -
Glucose / potassium chloride / sodium chloride Injectable Product
SCDG · 1165813
📦 FDA Products & Package NDCs
10 products · 10 package NDCs
10 package NDCs map to RxCUI 1863975 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00338-0603-03 | 500 mL in 1 BAG (0338-0603-03) | Potassium Chloride in Dextrose and Sodium Chloride | Baxter Healthcare Company | 1982-03-23 |
| 00338-0663-04 | 1000 mL in 1 BAG (0338-0663-04) | Potassium Chloride in Dextrose and Sodium Chloride | Baxter Healthcare Company | 1979-02-02 |
| 00338-0669-04 | 1000 mL in 1 BAG (0338-0669-04) | Potassium Chloride in Dextrose and Sodium Chloride | Baxter Healthcare Company | 1979-02-02 |
| 00338-0671-04 | 1000 mL in 1 BAG (0338-0671-04) | Potassium Chloride in Dextrose and Sodium Chloride | Baxter Healthcare Company | 1979-02-02 |
| 00338-0673-04 | 1000 mL in 1 BAG (0338-0673-04) | Potassium Chloride in Dextrose and Sodium Chloride | Baxter Healthcare Company | 1979-02-02 |
| 00338-0675-04 | 1000 mL in 1 BAG (0338-0675-04) | Potassium Chloride in Dextrose and Sodium Chloride | Baxter Healthcare Company | 1979-02-02 |
| 00338-0803-04 | 1000 mL in 1 BAG (0338-0803-04) | Potassium Chloride in Dextrose and Sodium Chloride | Baxter Healthcare Company | 1985-04-05 |
| 00338-0807-04 | 1000 mL in 1 BAG (0338-0807-04) | Potassium Chloride in Dextrose and Sodium Chloride | Baxter Healthcare Company | 1985-04-05 |
| 65219-0151-75 | 20 BAG in 1 CASE (65219-151-75) / 500 mL in 1 BAG (65219-15... | Potassium Chloride in Dextrose and Sodium Chloride | Fresenius Kabi USA, LLC | 2022-09-02 |
| 65219-0153-10 | 10 BAG in 1 CASE (65219-153-10) / 1000 mL in 1 BAG (65219-1... | Potassium Chloride in Dextrose and Sodium Chloride | Fresenius Kabi USA, LLC | 2022-09-02 |
Observed labelers:
Baxter Healthcare Company (8) ·
Fresenius Kabi USA, LLC (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.